Design, synthesis, and enzymatic characterization of quinazoline-based CYP1A2 inhibitors

https://doi.org/10.1016/j.bmcl.2019.126719Get rights and content

Abstract

Cytochrome P450 isozyme 1A2 (CYP1A2) is one main xenobiotic metabolizing enzyme in humans. It has been associated with the bioactivation of procarcinogens, including 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), a tobacco specific and potent pulmonary carcinogen. This work describes the computational design and in-silico screening of potential CYP1A2 inhibitors, their chemical synthesis, and enzymatic characterization with the ultimate aim of assessing their potential as cancer chemopreventive agents. To achieve this, a combined classifiers model was used to screen a library of quinazoline-based molecules against known CYP1A2 inhibitors, non-inhibitors, and substrates to predict which quinazoline candidates had a better probability as an inhibitor. Compounds with high probability of CYP1A2 inhibition were further computationally evaluated via Glide docking. Candidates predicted to have selectivity and high binding affinity for CYP1A2 were synthesized and assayed for their enzymatic inhibition of CYP1A2, leading to the discovery of novel and potent quinazoline-based CYP1A2 inhibitors.

Section snippets

Declaration of Competing Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Acknowledgements

The work was part-funded by R01CA193286 (CX), College of Pharmacy Frank Duckworth Endowment (CX), and University of Florida Health Cancer Center Startup fund (CX).

References (13)

  • National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health....
  • Hu SS. Tobacco product use among adults—United States, 2013–2014. MMWR Morbidity and Mortality Weekly Report....
  • Group UCSW. US Cancer Statistics Data Visualizations Tool, based on November 2017 submission data (1999–2015): US...
  • G. Akopyan et al.

    Understanding tobacco smoke carcinogen NNK and lung tumorigenesis

    Int J Oncol

    (2006)
  • S.S. Hecht

    Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines

    Chem Res Toxicol

    (1998)
  • M. Nakajima et al.

    Inhibition and inactivation of human cytochrome P450 isoforms by phenethyl isothiocyanate

    Drug Metab Dispos

    (2001)
There are more references available in the full text version of this article.
View full text